JIMSMENews

Follow us : Mail

Ganga Pharmaceuticals- Standalone HY1-FY21 PAT dips to Rs 1.65 lacs against Rs. 15.53 lacs in HY1-FY20


Ganga Pharmaceuticals- HY1-FY21 Earning per share was Rs.0.04 which is the same to the EPS in HY1-FY20.

Company : Ganga Pharmaceuticals Ltd

Ganga Pharmaceuticals announced its standalone financials for the half year ended on 30thsept, 2020.

Following are the standalone financial figures for the HY1-FY2021 at Ganga Pharmaceuticals:

- Net profit falls to Rs.1.65 lacs against Rs. 15.53 lacs in a year ago period.

- Revenue stood at Rs.1.21 crore whereas last year corresponding period it was Rs.1.45 crore.

- Earning per share was Rs.0.04which is the same to the EPS in HY1-FY20.

By the end of financial year 2019-20, standalone total revenue at Ganga Pharmaceuticals reached Rs.3.24 crore against Rs.3.50 crore a year ago. PAT for FY20 was Rs.18.88 lacs while last year it was Rs. 18.71 lacs. Standalone EPS was Rs.0.46 against the same EPS last year.


Recent Stories

Weekly Journal

Get weekly updates on latest SME news in your e-mail.


Weekly Journal
Get weekly updates on latest SME news in your e-mail.
Terms of Use |Privacy Policy
Copyright © 2019 JimSMEnews. The JimSMEnews is not responsible for the content of external sites. Read about our approach to external linking.